Esketamine nasal spray for treatment-resistant depression

Review proposal consultation

Review proposal paper (PDF 164 KB)

Stakeholder matrix (MSWord 52 KB)

Review Decision paper (MSWord 36 KB)

Consultation response form (MSWord 77 KB)

Equality Impact Assessment (Guidance development) (PDF 192 KB)

Register of interests (PDF 166 KB)

Final draft guidance: post-appeal

Final appraisal document post-appeal (PDF 473 KB)

Public committee slides (PDF 258 KB)

Appeal

Janssen : Appeal letter (MSWord 115 KB)

Janssen : Appeal letter (MSWord 641 KB)

Royal College of Psychiatrists : Appeal letter (MSWord 71 KB)

Janssen : Scrutiny letter (MSWord 73 KB)

Royal College of Psychiatrists : Scrutiny letter (MSWord 68 KB)

Janssen : Response to scrutiny letter (MSWord 108 KB)

Royal College of Psychiatrists : Response to scrutiny letter (MSWord 23 KB)

Janssen : Final scrutiny letter (MSWord 75 KB)

Royal College of Psychiatrists : Final scrutiny letter (MSWord 63 KB)

Appeal decision (PDF 350 KB)

Final draft guidance: 2

Final appraisal document 2 (PDF 452 KB)

Public committee slides 3 (PDF 717 KB)

Public committee slides 4 (PDF 1.07 MB)

Committee papers 3 & 4 (PDF 4.37 MB)

Draft guidance: 2

Appraisal consultation document (online commenting)

Appraisal consultation document (PDF version) (PDF 426 KB)

Committee papers (PDF 2.25 MB)

Public committee slides (PDF 1.32 MB)

Draft guidance

Appraisal consultation document (PDF version) (PDF 312 KB)

Appraisal consultation document (online commenting)

Public committee slides (PDF 1.15 MB)

Committee papers (PDF 7.05 MB)

Final scope (PDF 190 KB)

Final stakeholder list (PDF 197 KB)

NICE's response to comments on the draft scope and provisional stakeholder list (PDF 241 KB)

Equality impact assessment (Scoping) (PDF 126 KB)

Draft scope pre referral (PDF 335 KB)

Draft scope pre referral (PDF 335 KB)

Draft matrix pre referral (PDF 271 KB)

Draft matrix pre referral (PDF 271 KB)